Point-of-Care Quantitation of Sputum Neutrophil Elastase Activity in Chronic Airway Disease

慢性气道疾病痰中性粒细胞弹性蛋白酶活性的护理点定量

基本信息

项目摘要

PROJECT SUMMARY Cystic fibrosis (CF) is a debilitating, progressive lung disease that currently has no cure. With proper management, patients can achieve good symptom control and quality of life. Exacerbations are acute episodes of worsening of respiratory symptoms, often triggered by an infection. During exacerbations, excess neutrophil elastase (NE) is released into the lung and causes irreversible damage to lung tissue. This enzyme can be detected in sputum and therefore serves as a biomarker for acute exacerbations. We hypothesize that daily, remote monitoring of this enzyme in CF patient sputum would result in more effective treatment and a reduction in lung tissue damage. Therefore, the objective is to develop a portable, point-of-care assay that can be used by CF patients to monitor NE activity in their sputum. The testing platform will consist of a magnetic chip reader and a disposable biosensor chip that has been pre- functionalized with NE-specific cleavable peptides attached to magnetic nanoparticles (MNPs). The peptides will serve as linkers between the sensor surface and the MNPs. Cleavage of peptides by NE will release the MNP resulting in a quantitative decrease in signal over time. The rate of peptide cleavage correlates with NE abundance. Therefore, when NE increases in sputum, this device will notify clinicians that an acute exacerbation is beginning. The ability to detect and quantify NE activity will be determined by how well this enzyme can cleave surface immobilized peptide substrates. Therefore, in Aim 1, we will use 96-well plate assays to evaluate different surface chemistries for optimal attachment of the peptide. To facilitate efficient cleavage by NE, we will optimize the density and length of the peptide substrate. Once optimized, the peptide substrate will be immobilized to the magnetic sensor surface and the fluorescent reporter used in the 96-well plates will be replaced with MNPs. In Aim 2, addition of either purified NE or patient sputum samples will result in cleavage of the peptide and a decrease in magnetic resistance as the MNPs are released from the sensor surface. This wash-free protease assay can be monitored in real-time enabling a “sample-to-answer” testing procedure that can be run by untrained professionals. While our proposed research will focus on sputum from CF patients, this assay will be suitable for use by patients with other chromic airway diseases, including Chronic Obstructive Pulmonary Disease (COPD).
项目摘要 囊性纤维化(CF)是一种令人衰弱的,进行性肺部疾病,目前尚无治愈。适当 管理,患者可以实现良好的症状控制和生活质量。加剧是急性情节 担心呼吸道症状,通常是由感染引起的。在加剧期间,超过中性粒细胞 弹性酶(NE)被释放到肺部,并对肺组织造成不可逆转的损害。这个酶可以是 在痰液中检测到,因此是急性加重的生物标志物。我们每天假设这一点, 在CF患者痰液中远程监测该酶会导致更有效的治疗和减少 在肺组织损伤中。因此,目的是开发一种便携式的,即保健的测定法 CF患者监测痰液中的NE活性。 测试平台将由磁芯片读取器和一次性生物传感器芯片组成 用连接到磁性纳米颗粒(MNP)的NE特异性切解辣椒官能化。辣椒会 用作传感器表面和MNP之间的接头。 NE裂解Petides将释放MNP 随着时间的流逝,信号的定量减少。胡椒裂解的速率与NE相关 丰富。因此,当NE增加痰液时,该设备将通知临床医生急性加重 正在开始。 检测和量化NE活性的能力将取决于该酶清除表面的能力 固定的肽底物。因此,在AIM 1中,我们将使用96孔板测定法来评估不同的表面 化学以最佳的肽附着。为了促进NE的有效分裂,我们将优化 肽底物的密度和长度。一旦优化,肽底物将被固定在 磁传感器表面和96孔板中使用的荧光记者将被MNP替换。在 AIM 2,添加纯化的NE或患者痰液样品将导致胡椒和A裂解 当MNP从传感器表面释放时,磁电阻的降低。这种无洗的蛋白酶 可以实时监控测定,启用可以通过 未经训练的专业人员。虽然我们提出的研究将侧重于CF患者的痰液,但此测定将是 适用于其他铬酸气道疾病的患者使用,包括慢性阻塞性肺 疾病(COPD)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Drew Alexander Hall其他文献

Drew Alexander Hall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Drew Alexander Hall', 18)}}的其他基金

Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging opioid and other drug threats
开发和验证一种新型即时护理技术,用于快速非靶向识别新出现的阿片类药物和其他药物威胁
  • 批准号:
    10775250
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

2/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD
2/2 慢性阻塞性肺病多中心 CLEAN AIR 2 随机对照试验
  • 批准号:
    10722232
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
  • 批准号:
    10724042
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
  • 批准号:
    10723956
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Sources and Regulation of Epithelial Stem/Progenitor Cells in Alveolar Regeneration
肺泡再生中上皮干细胞/祖细胞的来源和调控
  • 批准号:
    10747042
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了